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Abstract 
 
 
Chemiluminescence assays are used widely for the detection of nitric oxide (NO)-derived 
species in biological ﬂuids and tissues. Here we demonstrate that these assays can be 
interfaced with mass-sensitive detectors for parallel determination of isotopic abundance. 
Results obtained with tri-iodide and ascorbic acid-based reductive assays indicate that 
mass spectrometric detection enables NO isotope-tracing experiments to be carried out to 
a limit of detectability of a few picomol, a sensitivity similar to that of standard gas phase 
chemiluminescence methods. The advantage afforded by mass spectrometric detection is 
demonstrated using the murine macrophage cell line J774, which is shown here to reduce 
15NO – to 15NO – under anoxic conditions. The particular combination of an analytical and 
3 2 
cellular system described here may hold promise for future characterization of the enzymatic 
pathways contributing to mammalian nitrate reductase activity, without background 
interference from 14NO – derived from other sources. 
 
 
Keywords: chemiluminescence assay; isotope tracing; mass spectrometer; nitrate; nitrate 
reductase; nitric oxide, nitrite. 
 
 
 
 
Introduction 
 
 
Nitric oxide (NO) plays an important role in cell signaling by promoting a wide range of 
posttranslational protein modiﬁcations, such as heme nitrosylation and S-nitrosation. Despite 
the attention that these signaling mechanisms have received in the last two decades, there 
remains much ambiguity about the precise chemical pathways that link NO sources to the 
resulting protein modiﬁcations. For instance, the classical NO-signaling pathway involving 
heme-nitrosylation, which includes the prototypical activation of soluble guanylyl cyclase, is 
widely viewed as arising from capture of NO generated from local enzymatic NO synthesis 
via oxidation of L-arginine. It is now recognized that nitrite (NO ˉ) may also contribute to 
hemeprotein nitrosylation via interaction with the mitochondrial electron transport chain 
(Walters et al., 1967; Nohl et al.; 2000, Tischner et al., 2004), deoxyhemoglobin (Cosby et al., 
2003: Hunter et al., 2004), myoglobin (Rassaf et al., 2007; Shiva et al., 2007; Hendgen-Cotta 
et al., 2008), xanthine oxidase (Li et al., 2004; Webb et al., 2004), non-enzymatic formation of 
NO as a result of disproportionation of nitrous acid (Zweier et al., 1995; Hunter et al., 2004), 
and a co-operative mechanism between hemes and thiols (Bryan et al., 2005). In the case of 
protein S-nitrosation, the process can potentially occur through many intermediate pathways 
that involve reactions with higher order nitrogen oxides (e.g. N O or N O ) (Williams, 1988) 
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superoxide (Schrammel et al., 2003), metal ions (Williams, 1988; Stubauer et al., 1999), thiyl 
radicals (Jourd’heuil et al., 2003) and nitrite (Bryan et al., 2005). Further compounding this 
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complexity, the chemical pathways connecting NO sources to potential protein modiﬁcations 
are critically dependent on intracellular conditions (e.g. oxygen tension, pH, redox state), on 
the presence of hydrophobic regions in proximity to NO sources (Liu et al., 1998), and on the 
nature of the protein microenvironment around the thiol group (Stamler et al., 1997; Ascenzi 
et al., 2000). The multiplicity of potential pathways is thus leading to a growing realization 
that much work remains to be done before the role NO plays in cellular function can be fully 
characterized. Attaining this level of understanding will require a combination of analytical 
tools that not only are capable of detecting biologically relevant levels of NO-related products, 
but also able to trace their chemical origin through isotopic differentiation. 
 
 
A common approach for the detection of biologically generated NO species is the NO 
chemiluminescence assay. This approach relies on the extraction of NO from selective species, 
either chemically or optically, and their subsequent detection with an NO chemiluminescence 
detector where trace levels of NO are detected in the gas phase through its chemiluminescent 
reaction with ozone (Fontijn, 1970). When coupled to the gas efﬂux from purge vessels 
containing reducing/oxidizing solutions or from UV irradiated capillaries, this detector can 
quantify NO products, including nitrite and nitrate (Walters et al., 1978; Cox and Frank, 
1982; Dunham et al., 1995; Yang et al., 1997; Trushina et al., 1997), nitroso products 
(Massey et al., 1984; Stamler et al., 1992; Samouilov and Zweier, 1998; Ewing and Janero, 
1998; Gladwin et al., 2000; Rassaf et al., 2002; Jourd’heuil et al., 2005; Wang et al., 2005; 
Zhang et al., 2005), nitrosyl-hemes (Gladwin et al., 2000; Feelisch et al., 2002) and total 
NO (Sonoda et al., 1997). The wide use of NO chemiluminescence detectors in life science 
laboratories can be attributed to several factors, including sensitivity, selectivity, quick 
response, ease of use, and the relatively moderate pricing and space requirements that are 
comparable to other commonly used laboratory instruments. Here we describe an enhancement 
to NO chemiluminescence assays that retains their original advantages while providing 
isotopic differentiation capabilities.  Following earlier work by Russow (1999) on mass 
spectrometric detection of NO from aqueous nitrite and nitrate using a chemical vessel, this 
work demonstrates that a mass spectrometer detector can either replace, or operate in parallel 
with, NO chemiluminescence detectors without altering assay conditions and sacriﬁcing 
convenience. The approach incorporates a detector that is commonly used in GC/MS systems, 
which is also sold as a stand-alone system with supporting data acquisition software. Our 
results indicate that mass spectrometric detection used in this way allows NO isotopic-tracing 
experiments to be carried out to a limit of detectability of a few picomoles. The advantage 
afforded by mass spectrometric detection is illustrated by providing evidence that the murine 
macrophage J774 displays nitrate reductase capabilities, as demonstrated by the emergence of 
15NO – immediately following the addition of 15NO – to cell lysates. 
2 3 
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Results 
 
 
Apparatus 
The apparatus described here for the isotopic detection of NO products is shown schematically 
in Figure 1. The setup is based on those designed previously for the use of NO-ozone 
chemiluminescence detection (CLD), with a few modiﬁcations to accommodate the added 
mass-sensitive detector (MSD) and to control the relative ﬂow toward both instruments. The 
CLD in our lab is a Dasibi 2108 (Dasibi Environmental Corp., Glendale, USA), modiﬁed to 
process the output from the photomultiplier tube (PMT) directly into a DAT-710 A/D converter 
(DataQ Instruments, Akron, OH, USA) using a sampling rate of 1 Hz. The nominal intake ﬂow 
rate for this instrument is 100 ml/min and the NO sensitivity under direct PMT monitoring is 
approx. 10 ppb. The MSD used here (5975B XL; Agilent Technologies, CA, USA) employs 
electron impact ionization and a high-volume turbopump (ca. 260 l/min). The ﬂow to the MSD 
is restricted by a 0.25mm ID fused silica gas chromatography (GC) column measuring 7.5 m 
in length, resulting in an intake ﬂow rate of 4 ml/min for an input pressure of 2 atmospheres. 
The column is maintained at all times at a temperature of 100°C inside an oven (1321F; VWR, 
West Chester, PA, USA) to prevent accumulation of adsorbed gases that may occur primarily 
when the apparatus is not in use. A hole two inches in diameter was bored through the side of 
the oven to accommodate the MSD inlet in order to prevent condensation of volatile species at 
that point. The MSD is operated in selected ion monitoring (SIM) mode, scanning for masses 
m/z = 29, 30, and 31. Integration times were set to either 100 ms for scanning conditions 
using MSD auto-tuning parameters or 400 ms when operating under manually adjusted MSD 
parameters (see below). 
 
 
Samples containing NO related products are injected into a 40 ml Sievers purge vessel (GE 
Analytical Instruments, Boulder, CO, USA), containing a suitable reactive solution that strips 
the NO off its binding site and releases it into the gas phase. The vessel is continuously purged 
with ultrahigh-purity helium (UHP He) with an inlet gauge pressure of typically 20-40 psi 
(135-270 kPa) that rapidly extracts dissolved NO from the solution and transports it at rates of 
50-100 ml/min towards the detectors for quantiﬁcation. Water vapor transported by the carrier 
gas is partially recondensed by the jacketed condenser that is built into the Sievers purge 
vessel, maintained here near 0°C. The remaining gas is ﬁltered through a 10 ml Sievers purge 
vessel containing a 1 M solution of NaOH to trap corrosive gases and higher order nitrogen 
oxides. Finally, the water vapor of the gas en route to the detectors is reduced by the condenser 
built into the second purge vessel, which is also maintained near 0°C. 
 
 
The gas sample emerging from the chemical vessels is split by a Swagelok T connector 
between the two detectors. The majority of the ﬂow (>90%) is directed toward the CLD since 
the MSD ﬂow is limited to 4 ml. To help maintain the intake pressure near 1 atm for the CLD, 
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the line leading to it is opened to the atmosphere with the aid of a T connector that is uncapped 
at one end. This open point also acts as a constant pressure point that helps to regulate upstream 
where the ﬂow splits toward the MSD. Exposure to atmospheric NO contributes minimally to 
our signals since our lab is located in a wooded campus within a relatively small metropolitan 
area. In areas where NO levels are higher and variable, the same pressure regulation could be 
achieved with the aid of a balloon attached to the open end, which is ﬁlled periodically with 
He. Finally, a needle valve between the two T’s adjusts the ﬂow through that line in order to 
control the balance of ﬂow between the MS and CL detectors. 
 
 
Even with non-detectable levels of atmospheric NO, air contamination in the gas stream 
can produce small contributions to the signals at m/z = 30 as demonstrated in Figure 3. The 
contribution at m/z=30 is likely due to the partial fragmentation of O and N in the ion source, 
followed by recombination into NO. The signal observed at m/z=31 always tracks the levels of 
at m/z=32 and is likely due to crosstalk between the two mass channels. Control of air leaks 
into the gas lines is therefore critical for proper quantiﬁcation of NO with minimal interference. 
Since molecular oxygen can diffuse with ease through plastics, care is taken to avoid using 
these materials in the gas lines. Our apparatus makes use of 1/8 inch (3.2 mm) stainless steel 
(SS) tubing, except for a portion leading to the chromatography (GC) column which used 
1/16 inch (1.8 mm) tubing. All tubing is joined with SS Swagelok connectors. Coupling of the 
GC column to the 1/16 inch tubing is achieved with a Valco 1/16 inch stainless steel internal 
union with a fused silica adapter ferrule on the column side. In addition to air tight tubing and 
junctions, our apparatus makes use of injection septa designed for GC injectors. Another factor 
that affects these levels is contamination of the lines leading to the MSD, which is particularly 
evident when they are opened and exposed to atmospheric gases. For this reason we typically 
isolate those lines at the end of the day by shutting the switch-valve and the Teﬂon valve at 
the exit of the second condenser and keeping the MSD running continuously. In addition to 
leaks, one must contend with dissolved air that may be present in solution. For samples that 
can be studied under anoxic conditions, the air contamination can be eliminated simply by 
purging with pure argon for 30 seconds prior to injection into the reaction vessel. Whenever 
experiments require extended periods of purging, e.g. biological samples that must be 
maintained anoxic for several minutes, it is recommended that the gas be scrubbed with NaOH 
to trap NOx contaminants that may result in the creation of artifactual NO-related products. 
When normoxic or hypoxic conditions are required, we resort to an analytical procedure that 
uses information obtained from m/z = 29 to subtract the contributions due to contamination at 
m/z = 30 and 31. This procedure is discussed below in the section. 
 
 
As illustrated in Figures 1-5, signals obtained with MS detection are very similar in lineshape 
to those obtained with chemiluminescence (Feelisch et al., 2002). They are best described 
by exponentially modiﬁed gaussian functions, resulting from the convolution of gaussian 
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processes such as diffusion of gases, and exponentially decaying processes such as reaction 
kinetics in the purge vessel, extraction of the analytes from the reducing solution, and detector 
response. Our analysis software (Peakﬁt, Systat Software, CA, USA) allows for incorporation 
of this proﬁle information to determine the best peak ﬁt, underlying background, and area 
under the peak. Figure 2 shows a representative curve ﬁt obtained with a 100 pmol injection of 
nitrite into a tri-iodide assay. 
 
 
Performance under autotuned MSD operation and with minimal signal processing In this 
section we describe the performance of MSD based NO detection under two experimental 
conditions that facilitate MSD operation and minimize signal processing: autotuning MSD 
operation and use of He under high pressure/ﬂow settings. Autotuning offers a hands-free 
approach to maintaining instrument sensitivity and selectivity. It allows a mass spectrometer to 
determine its own voltage and current settings that ionize and guide molecules towards their 
detectors. The performance is optimized for selectivity and sensitivity over a wide range of 
molecular masses, but not necessarily for smaller mass ranges such as the one targeted in this 
study. The second aforementioned experimental condition is the adoption of pressure settings 
that in our experience minimizes baseline ﬂuctuations and thus facilitates subsequent signal 
analysis. Those were found to occur at a supply and split ﬂow gauge pressures of 40 and 32 
psi, respectively. In the next section we describe other conditions that require additional 
optimization and signal processing but provide greater sensitivity. Both approaches are 
presented separately here in the interest of those who may wish to duplicate 
our system for the following reasons. The ﬁrst approach is easier to implement and may be 
sufﬁciently sensitive to quantify NO products in e.g. translational studies using biological 
ﬂuids such as plasma and urine. Furthermore, it offers a valuable benchmark to meet before 
attempting to implement the more advanced changes that provide greater sensitivity. 
 
 
Typical MSD tracings extracted for the signals at m/z = 29, 20, and 31 are shown in Figure 3. 
The curves illustrate the performance of the system obtained with 1 nmol injections of 14NO –, 
15NO –, and of an equimolar mixture of 14NO – and 15NO –, all in Ar-purged PBS. The fourth 
2 2 2 
injection illustrates the signals generated by dissolved air in fully aerated buffered solutions. 
Large amplitude signals are seen with every injection, with ionic masses in accordance to 
the substances injected and to their proportions. The large peak arises from 14N15N (natural 
abundance of 0.73%). Smaller artifactual signals are also seen in adjacent mass channels. 
The smaller signal registered at m/z=31 during the ﬁrst injection of 14NO – arises in part from 
the isotopic contribution from 15N16O and 14N17O (total natural abundance of 0.4%) with the 
remaining contribution (approx. 0.6%) arising from cross-talk with the m/z=30 signal. The next 
injection of 15NO – also displays a small signal at m/z=30 corresponding to a 2% fraction of the 
1 nmol injection of 15NO –. This fraction is consistent with the 2% 14NO – impurity level quoted 
2 2 
by the 15NO – supplier. Lastly, the small signals at m/z = 30 and 31 seen with injections of a 
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fully aerated PBS sample arise from 14N16O formed by partial fragmentation of O and N in the 
ion source, and from crosstalk between the larger signal at m/z=32 (16O16O) and m/z=31. 
 
 
To test the linearity of our MSD approach and its correlation with chemiluminescence 
detection, 100 µl solutions of 15NO – with concentrations of 100 nM, 300 nM, 1 µM, 3 µM 
and 10 µM, where injected in triplicate into an I–/I –/HCl reductive assay (see Figure 4). The 
top panel of Figure 4 shows a realtime scan extraction for m/z = 31 corresponding to the 
expected mass for 15NO. The peak areas for those injections are shown in the middle panel of 
Figure 4 as a function of 15NO – injected. The linearity of the response is evaluated through 
a power law ﬁt y = axb and resulted in a near-unity power dependence with b=0.9733. The 
lower panel compares the same integrated signals with those obtained simultaneously with a 
chemiluminescence detector. The near-linear relationship between the two conﬁrms that the 
MSD signals observed are due to the detection of NO.  Similar MSD limearity and correlation 
with chemiluminescence detection were obtained with injections of 14NO – and monitoring of 
m/z 30 (data not shown). 
 
 
Similar experiments were conducted with the nitrite speciﬁc reactive mixture containing 
ascorbic acid and HCl. Compared to the tri-iodide assay, the ascorbic acid based assay 
produces broader temporal signals with consequently lower limits of detection (approx. 30 
pmol, see Figure 5, top panel). 
 
 
Extended performance using reduced purge ﬂow, manual tuning, and background 
subtraction 
Additional hardware adjustments and signal processing have enabled us to achieve extended 
performance in terms of sensitivity and in the ability of handling aerated samples. To attain 
higher signals we lowered the ﬂow rate to the chemiluminescence relative to that into the MS 
detector. Best results were achieved at a He supply and split-ﬂow gauge pressures of 20 psi 
and 17 psi, respectively. Under these operating conditions we observe that the duration of the 
NO signals is increased from 0.2 to more than 0.8 minutes. Further gain in signal to noise 
ratio were attained with adjustments to parameters that control the performance of the MSD 
analyzer. One simple adjustment takes advantage of the fourfold increase in duration of the NO 
signals registered under lower ﬂow conditions. This enabled us to decrease the sampling rate 
fourfold by increasing the integration time from 100 to 400 ms per ion. A four-fold increase 
in integration time resulted in a twofold increase in signal to noise ratio. Additional sensitivity 
was obtained with manual adjustments to default and autotuned parameters that control the 
MSD analyzer. Using an electron ionization current of 60.6 µA, and voltages for ion focusing, 
the repeller, entrance lens, and entrance lens offset of 90.2V, 30.12V, 40.0V, and 15.31V, 
respectively, we were able to increase the integrated signal another fourfold without signiﬁcant 
changes in background noise. 
Isotope tracting for NO chemiluminescence assays  
 
 
 
 
A drawback from lower pressure operation is the emergence of ripples in the baseline with a 
period also on the order of a minute, as illustrated in middle panel of Figure 5. The nature of 
the ripple is unclear at this time since it manifests itself at only at selected m/z ions including 
all the ones monitored here. However, since the ripples at m/z = 30 and 31 are consistently 
in phase with the one at m/z=29, we followed a simple procedure that uses the data from the 
latter to correct for the ripple in the former ions. To null the ripple at m/z=30, for instance, the 
data from m/z=29 was ﬁrst scaled down by a constant factor and then subtracted from the data 
at m/z=30. The factor selected corresponded to one that minimized the standard deviation for 
a portion of the subtracted curve that should normally be ﬂat, i.e. a portion before or after the 
signal. The minimization of the standard deviation can be accomplished manually by trial and 
error or using an automatic routine such as the Solver option available in Microsoft Excel. 
The effectiveness of this background subtraction procedure is illustrated in the lower panel of 
Figure 5. 
The background subtraction procedure outlined above proved effective for samples purged of 
air. For un-purged samples, where dissolved air produces artifacts as illustrated in Figure 3, we 
developed an additional procedure that subtracts the air artifacts from the signals. The relative 
contributions of air to the signals at m/z=29, 30 and 31 were ﬁrst determined using fully 
aerated buffer injections and Peakﬁt analysis. Once these contributions were standardized, the 
m/z=29 trace in the samples was inspected for air signals which were analyzed with Peakﬁt for 
amplitude and shape. This information together with the scaling factors obtained with aerated 
standards allowed us to estimate the anticipated amplitude and shape of air contributions at 
m/z=30 and 31. Once those contributions were subtracted from the data in all three traces the 
ripple subtraction and signal analysis proceeded as outlined above. 
Together, the adjustments made to the ﬂow through the purge vessels and to the MSD 
analyzer increased our overall signal to noise ratio by nearly one order of magnitude. Figure 7 
demonstrates the increased sensitivity achieved when all enhancements described above were 
implemented. The results show that signals as low as 3 picomoles could be quantiﬁed using 
the ascorbic acid assay. Similar performance (data not shown) was achieved using the tri- 
iodide based assay. Although the adjusted values quoted here are largely speciﬁc for the mass 
spectrometer model we use, it suggests that similar adjustments when implemented with other 
models could likely result in signiﬁcantly enhanced performance. 
 
 
Isotopic detection in J774 cells 
There is currently much interest surrounding the biological activity and therapeutic uses of 
nitrite, an oxidative product of NO synthesis that until recently was regarded as biologically 
inert (Gladwin et al., 2005). The interest in this anion has been intensiﬁed further with recent 
evidence that mammalian tissues can reduce nitrate to nitrite through the action of xanthine 
oxidase (Jansson et al., 2008), an enzyme that plays a signiﬁcant role in the immune system. 
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Since macrophages are part of that system and constitutively express this enzyme, we sought to 
explore whether these cells are able to reduce 15NO – (nitrate) to 15NO – (nitrite) using our mass 
3 2 
selective technique. 
 
 
A representative set of data from our mass selective experiments is shown in the top panel of 
Figure 7. The hatched gray zone around the horizontal axis represents our limit of detectability, 
i.e. the area where measurements essentially correspond to baseline ﬂuctuations. Following 
J774.2 cell homogenization, samples were kept aerated at 37°C as 100 µl volumes were drawn 
periodically and injected into an ascorbic acid based nitrite assay. Each column in the Figure 
represents the average of three injections performed over a period of 20 minutes following 10 
minutes of Ar purging, for a total of 30 minutes. The gray and white columns in the top panel 
of Figure 7 show the levels of 14NO – and 15NO –, respectively, before and after addition of 100 
2 2 
µM 15NO – to the lysate at the 90 minute mark. The data shows the emergence of 15NO – only 
3 2 
after addition of 15NO –, consistent with the notion that J774.2 cells should exhibit nitrate 
reductase activity. Similar experiments performed with control culture ﬂasks incubated without 
J744.2 cells, conﬁrm that the 15NO – reduction is obtained only in the presence of cells. The 
lower panel of Figure 7 compares results obtained for 15NO – before and after addition of 100 
µM 15NO – to lysates, for Ar-purged and un-purged samples. These results demonstrate that the 
nitrate reductase activity of J774 cells is potently inhibited by oxygen. 
 
 
In addition to the signals obtained for 15NO –, the upper panel of Figure 7 illustrates the 
artifactual progressive increase in the 14NO – signal usually seen when a biological sample or 
culture media is purged with an industrial grade gas that has not been scrubbed with NaOH. 
The increase was not observed in our standards or PBS alone. This phenomenon is attributed 
to hydrolysis of NOx species present in the purge gas, which interestingly seems to be 
potentiated by the presence of biological material in the sample. The ability of our system to 
discern isotopically nitrate-to-nitrite reduction from other reactions that produce nitrite only 
demonstrates the advantage of using isotopic tracing methods to characterize sources of NO 
signaling. 
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Discussion 
 
 
The current work demonstrates that mass spectrometric detection can be successfully 
incorporated into NO chemiluminescence assays with relative ease to provide isotopic 
tracing capabilities. The system described here places an MS detector in parallel with an NO 
chemiluminescence detector mainly to validate our ﬁndings, but the MS detector could have 
easily been used as the sole detector in the system if desired. The limit of detection for both 
14NO and 15NO is on the order of a few pmol using the MSD option, rendering it nearly as 
sensitive as chemiluminescence detection. Tests with cell homogenates indicate that these 
detection limits are also attainable in with biological samples. 
 
 
The present technique offers advantages and imposes limitations that should be considered 
carefully before adopting it. The main advantage of our MS based technique is its direct 
compatibility with chemiluminescence based NO assays, which not only allows it to use 
extensively validated chemical assays but also facilitates cross-referencing of results obtained 
by either technique. The benchtop space requirements and the detector costs are also 
essentially similar for either technique. Another advantage associated with MS detectors 
is that their technology has matured to the point of providing turn-key operation and easy 
servicing steps. Consumable items such as electron impact ﬁlaments, detector horns, capillary 
columns, are widely available through a variety of vendors at competitive pricing. Compared 
to costlier and more labor-intense GC/ Negative Ion Chemical Ionization MS techniques that 
rely on derivatization of NO-related products (Tsikas, 2000), the current technique offers the 
advantage that biological samples can be assessed for nitrite, nitroso, and nitrosyl-heme species 
within a few minutes and with minimal sample preparation. Finally, unlike laser IR techniques 
reported to date which enable sensitive detection of 14NO or 15NO, but not both simultaneously 
(Gabler and Lehmann, 2005; Yi et al., 2006; Fritsch et al., 2008), our MS approach is able 
to cycle between those two detection channels in only a few milliseconds therefore allowing 
simultaneous detection of 14NO and 15NO with equal sensitivity. Laser-based techniques are 
also signiﬁcantly costlier than the technique described here. 
 
 
In terms of disadvantages and limitations, the lowest concentration of NO-related products 
that can be quantiﬁed currently with our technique is on the order of tens of nM assuming 
that sampling is performed in 100 µl volumes. This level of sensitivity most likely precludes 
its use for studies of basal nitrosation and heme nitrosylation in small animals (Bryan et al., 
2004). Such products may be best studied using GC/MS (Tsikas, 2000) or one of the IR laser 
spectroscopic methods (Fritsch et al., 2008) alluded to above. Nevertheless the sensitivity 
of our technique should still be sufﬁcient to trace isotopically other products such as nitrite 
and nitrate in ﬂuids and tissues of small animals. Another disadvantage is the inconvenience 
imposed by the additional data processing steps required to subtract the contributions of 
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dissolved air from the NO signals. In the future, this inconvenience may be minimized through 
programmed steps using software developed in-house. 
 
 
Finally, we demonstrated the applicability of the present technique with experiments focused 
on the detection of nitrate-to-nitrite reduction in anoxic J774.2 cell lysates. When lysates were 
spiked with 15N-labeled nitrate, we observed very clearly its reduction to 15N-nitrite, even as 
the levels of 14NO – changed due to other processes.  Our analytical system also enabled us to 
determine that the reduction of nitrate to nitrite was distinctly suppressed in aerated samples. 
These results suggest that this cellular model combined with our analytical system may hold 
promise for future characterization of the enzymatic pathways contributing to mammalian 
nitrate reductase activity. 
 
 
Materials and methods 
 
 
Standard solutions of 14NO – and 15NO – were prepared from Na14NO and Na15NO (Sigma- 
2 2 2 2 
Aldrich, St. Louis, MO, USA) in 40 mM HEPES or phosphate-buffered saline (PBS) solutions. 
All samples were bubbled with argon (Ar) for 30 seconds prior to injection to remove dissolved 
air, which produces some interference at m/z = 30 and 31. They were then injected in 100µL 
volumes into a 40 mL Sievers reaction vessel containing either tri-iodide (Feelisch et al., 
2002) or ascorbic acid based solutions (Nagababu and Rifkind, 2007), in which 1 M HCl was 
substituted for acetic acid to avoid background interference from the molecular fragments 
CH OH at m/z = 31(NIST). The tri-iodide solution consisted of 1M HCl at room temperature, 
to which 10 mg of I and 300 mg of KI were added. The ascorbic acid solution was prepared 
from a mixture of 32 ml of 1 M HCl and 4 ml of 0.5 M ascorbic acid maintained at 37°C. The 
nitrite speciﬁcity of the ascorbic acid/HCl mixture was validated with side by side injections of 
nitrite, nitrate, and S-nitrosoglutathione (Sigma-Aldrich). The NO formed from the reduction 
of nitrite was purged out of the reaction vessel with ultrahigh-purity helium (UHP He) and 
scrubbed through a 1 M NaOH solution, and quantiﬁed with our combined CLD/MS detection 
system described in the following section. 
 
 
J774.2 cells (Sigma-Aldrich) were grown to near conﬂuence (5-7 days) in T75 ﬂasks with 
DMEM in the presence of 10% fetal bovine serum (Sigma-Aldrich), penicillin (200 U/ml), 
and streptomycin (200 µg/ml). On the day of the experiment, the cell culture supernatant 
was aspirated and the adherent cells were washed 2-3 times with sterile PBS. Cells were then 
collected by scraping using a rubber policeman into 1-2 ml of PBS and lysed using an Ar- 
pressurized Parr Bomb. The resulting cell lysate was used immediately in experiments. Control 
ﬂasks were incubated under identical conditions for the same period of time without cells and 
processed identically to those containing cells. In addition, the media from each of the control 
ﬂasks were centrifuged in 15 ml tubes, at 1000 g for 60 minutes. The remaining pellet was re- 
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suspended in 1 ml of PBS and tested immediately. 
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Figure legends 
 
 
Figure 1  Diagram highlighting key features of the setup for simultaneous detection of NO 
products using chemiluminescence and mass spectrometers detectors. 
 
 
Figure 2  Analysis of a 100 pmol signal generated with MS detection. 
The dots correspond to data points collected directly from the MSD, while the solid curve 
represents a data ﬁt to an exponentially modiﬁed Gaussian over a linearly graded background. 
Curveﬁtting is performed with Peakﬁt which automatically determines optimal parameters for 
the peak and the background, and automatically calculates the area under the peak. 
 
 
Figure 3 Typical MSD tracings extracted for the signals at m/z = 29, 30, and 31. 
The curves illustrate the performance of the system obtained with 1 nmol injections of 14NO –, 
15NO –, and of an equimolar mixture of  14NO – and 15NO –, all in Ar-purged phosphate-buffered 
2 2 2 
saline solution. The fourth injection illustrates the signals generated by dissolved air in fully 
aerated buffered solutions. The large peak arises from 14N15N (natural abundance 0.73%; see 
text for details). 
 
 
Figure 4  15NO – quantiﬁcation using a tri-iodide assay and standard MS detection conditions 
(see text). 
Top panel: realtime scan of multiple 15NO – injections of increasing concentration. Middle 
panel: areas under the curve for the injections shown in the top panel. Lower panel: comparison 
between the areas under the curve measured simultaneously with MS and CL detection. 
 
 
Figure 5  Performance comparison between autotune/high-pressure, manual-tune/low-pressure, 
and manual-tune/low-pressure/signal-subtraction modes of operation. 
All panels show signals obtained at m/z=30 with two injections of 30 pmol of 14NO – into 
an ascorbic acid/HCl assay. The upper panel shows barely discernable signals obtained with 
injections at 5 and 7.5 minutes under autotune/high-pressure conditions. The middle panel 
exempliﬁes the enhancement in performance that is achieved with lower pressure and MSD 
manual tuning. A drawback from this mode of operation is the emergence of ripple in the 
baseline with a period comparable to that of the signal. The lower panel demonstrates that 
much of the ripple can be eliminated by subtracting a fraction of the signal at m/z=29 to further 
enhance the sensitivity of the system. 
 
 
Figure 6  Quantiﬁcation of 14NO – (upper panel) and 15NO – (lower panel) using an ascorbic 
2 2 
acid/HCl assay and enhanced MS detection conditions (see text). 
 
 
Figure 7  Mass-selective detection of nitrite from the murine J774.2 macrophage cell line. 
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'l11e gray and white columns  in the top panel show the levels of 141\0 
2 
and 151\0 
2 
, respectively, 
before and after addition  of lOOf!m of 151\0 to the lysate at the 90 minute  mark The gray 
hatched  zone around the horizontal axis represents our limit of dctcctability, i,c, the area where 
measurements are essentially indistinguishable ±!·om baseline fluctuations The lower panel 
compares results  obtained  tor 15N0 prim·to and after addition  of 100 f!m of 151\0 to lysates, 
 
for i\r-purged samples  (white  columns) or un-purged  (hatched  columns), 
Isotope tracting for NO chemiluminescence assays  
 
 
 
NITRIC OXIDE 
 
 
 
PRESSURE 
SENSOR 
DETECTOR 
 
MASS 
SPECTROMETER 
DETECTOR 
 
 
 
FLOW RESTRICTOR 
(7.5 M GC COLUMN 
MAINTAINED AT 100°C) 
Isotope tracting for NO chemiluminescence assays  
 
 
65o.------.-----,------,----.------.------.650 
 
600+---·--·------------+---------------------------·-!----------------------------+------------1 +-----------+----------·--·----------------1---------------------------·--+600 
 
550+------------------------+----------------------------!---------------------------+-------+--+-----+---------------+------------------------- +550 
 
500+------------------+------------------------!----------------------------+---------/-----+-------+---------------------------+---------------------------+500 
 
4501-------- ---------!-----------------------------+---------/------+-----+---------------------------+----------------------------+450 
 
 
400+--------------+---------------+--------------- i-----+-----\-\-,+---------------!------------------ +400 
 
350+ ·················· +··················· i···············++·····\+ ·····+ ··················· +350 
 
300+-·················
\
;
.
lo ;
··. ·.·;.-
.
:·:
,
· 
·i·····
•
··
.
·
·
······· · jf
:. 
·····
 
--:-·  '·/ f"<'-". 
.
i
.
'
.-...
'
..
"'"
'::
·
.
-;·
--_
···+
:· ·-·-·-·-·-· +300 
:-.-·· 
250 ---------- 4------+------ ---+250 
31 32 33 34 
Isotope tracting for NO chemiluminescence assays  
2 
 
 
 
 
.5 nmoi 14No2· 
1 nmoi 
14
No2· .5 nmoi 15No · 
--.:!._..!:o-- 
 
 
mlz = 29 
 
 
 
[1 nmoi 15N02 --r-r- 
--.:!. ..!::- Aerated PBS 
 
 
m/z = 30 
 
 
 
 
 
 
 
 
 
m/z = 31 
• 
0 5 10 15 
Time (min) 
Isotope tracting for NO chemiluminescence assays  
: 
c. 
.e 
100 
· 
 
 
 
 
 
 
 
 
Q) 
() 
s:::: 
 
 
8000 
1000 pmol 
(II    6000 
"C 
s:::: 
::I 
 
(II 
<n 
4000 
 
 
2000 
 
 
10 pmol 30 pmol 
100 pmol 
300 pmol 
 
 
 
 
 
.._ \. 
 
6 10 16 20 26 30 36 40 
Time (min) 
 
 
 
1000  ------------ ---- --f-------- 
y = 1.1073x0 9733 
R
2 
= 0.9957 
 
II) 
 
Q,) 
 
"
.
C
s
 
 
.0s1 
c 
 
100 
 
 
 
 
 
10 
 
 
 
 
 
 
 
 
 
• 15N nitrite 
-Power fit 
 
1 
10  100 
 
pmol injected 
 
 
1000 
 
II)  1000-,-----------,-,----,----,---,------ 
ca 
e! 
ca 
ca 
Q,) 
c. 
Q,) 
(.) 
c 
Q,) 
(.) 
II) 
Q,) 
 
E 
.2 
E 
Q,) 
..c 
y = 1.2978x0 9654 
R
2  
= 0.9967 
 
 
 
 
 
 
 
 
 
 
 
 
• 15N nitrite 
-Power fit 
u 10+--------- ---- -- 
10 100 
MS peak  areas 
 
 
1000 
Isotope tracting for NO chemiluminescence assays  
 
 
 
 
3.9  4.9  5.9  6.9  7.9  8.9 
 
Manual tune 
 
 
10 12 14 
 
Manual Tune with 
background subtraction 
 
 
10 
Time (min) 
12  14 
Isotope tracting for NO chemiluminescence assays  
- 
Q) 
Q) 
- 
... 
 
 
 
 
 
 
 
 
1000 
y = 1.2936xo.9633 
R
2 
= 0.9961 
 
Ul 
.Ill: 
I'll 
a. 
"C 
$ 100 
!:!! 
Cl 
Q) 
s::::: 
 
10 
• 14N nitrite 
-Power fit 
 
 
1 10  100 
pmol injected 
1000 
 
 
 
 
 
 
 
 
 
Ul 
.Ill: 
I'll 
a. 
"C 
 
 
 
1000 
y = 0.9661x1.o3o3 
R
2  
= 0.9963 
$  100 
I'll 
Cl 
Q) 
s::::: 
 
10 
 
 
 
• 15N nitrite 
-Power fit 
 
 
1 10  100 
 
pmol injected 
1000 
Isotope tracting for NO chemiluminescence assays  
 
 
 
c "No; 
c '"No; 
25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
300 
c: 
 
a. 
200 
Cl 
E 
0 100 
E 
a. 
